Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Date of Purchase: April 29, 2025
- Shares Purchased: 858,187 ordinary shares
- Highest Price Paid: 380.10 pence per share
- Lowest Price Paid: 374.50 pence per share
- Volume Weighted Average Price: 377.03 pence per share
Material Changes and Capital Structure
Following the settlement of the buyback transaction, the company's registered share capital stands at 9,021,847,548 ordinary shares of £0.01 each. Of these, 4,080,205 are held as treasury shares. Consequently, the number of ordinary shares with voting rights is 9,017,767,343.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of the share transaction in accordance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased (858,187) against the company's cumulative buyback targets.
- Confirm the updated voting share count of 9,017,767,343 for disclosure threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Note that this filing does not contain operational or financial performance data for the period.